ArticleScience translational medicine2018

Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.

William C Stafford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.